DrugPatentWatch Database Preview

Details for Patent: 7,622,130

« Back to Dashboard

Which drugs does patent 7,622,130 protect, and when does it expire?

Patent 7,622,130 protects KYBELLA and is included in one NDA.

This patent has thirty-eight patent family members in twenty countries.

Summary for Patent: 7,622,130

Title:	Methods and compositions for the non-surgical removal of fat
Abstract:	Compositions and methods useful in the non-surgical removal of localized fat deposits in patients in need thereof using pharmacologically active detergents are disclosed. The pharmacologically active detergent compositions can additionally include anti-inflammatory agents, analgesics, dispersion agents and pharmaceutically acceptable excipients but do not contain phosphotidylcholine. The pharmacologically active detergent compositions are useful for treating localized accumulations of fat including lower eyelid fat herniation, lipodystrophy and fat deposits associated with cellulite and do not require surgical procedures such as liposuction.
Inventor(s):	Kolodney; Michael S. (Santa Monica, CA), Rotunda; Adam M. (Los Angeles, CA)
Assignee:	Los Angeles Biomedical Research Institute at Harbor UCLA-Medical Center (Torrance, CA) The Regents of the University of California (Oakland, CA)
Application Number:	11/054,171
Patent Claim Types: see list of patent claims	Use; Composition;

Drugs Protected by US Patent 7,622,130

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Patent Submitted
Kythera Biopharms	KYBELLA	deoxycholic acid	SOLUTION;SUBCUTANEOUS	206333-001	Apr 29, 2015		RX	Yes	Yes						METHOD FOR REDUCTION OF SUBMENTAL FAT

Non-Orange Book US Patents Family Members for Patent 7,622,130

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No.	Title	Estimated Patent Expiration
8,846,066	Methods and related compositions for reduction of fat and skin tightening
7,754,230	Methods and related compositions for reduction of fat
8,298,556	Methods and related compositions for the non-surgical removal of fat

International Family Members for US Patent 7,622,130

Country	Document Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	518565
Austria	521355
Australia	2005245002
Canada	2567298